The GCT team is glad to announce that the company’s President, Dr J.Apter, will be attending the Alzheimer’s Association International Conference from 28 July to 1 August in Philadelphia, USA.
The aim of event is to share theories, breakthroughs and best practices on dementia research. AAIC provides an opportunity to gather with researchers, clinicians and dementia specialists. It is an excellent resource for improving the diagnosis, risk reduction and treatment of Alzheimer’s disease and other dementias. Our company is committed to staying informed and updated on the latest developments in Alzheimer’s research, and looks forward to sharing knowledge and networking with others in the field.
You can request a meeting with Jeffrey Apter at bd@gctrials.com for further conversation.